Pharsight

Drugs that contain Nevirapine

1. List of Viramune Xr drug patents

VIRAMUNE XR's oppositions filed in EPO
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8460704 BOEHRINGER INGELHEIM Extended release formulation of nevirapine
Mar, 2029

(5 years from now)

Do you want to check out VIRAMUNE XR patents from before 2022?

Market Authorisation Date: 25 March, 2011

Treatment: Treatment of hiv-1 by once daily administration

Dosage: TABLET, EXTENDED RELEASE;ORAL

How can I launch a generic of VIRAMUNE XR before it's patent expiration?
More Information on Dosage

VIRAMUNE XR family patents

3

United States

2

Peru

1

Colombia

1

Ecuador

1

Australia

EA

1

EA

1

Korea, Republic of

1

Canada

1

New Zealand

1

Denmark

1

Spain

1

Tunisia

1

Uruguay

1

Chile

1

Ukraine

1

Poland

1

Japan

1

Morocco

1

Hong Kong

1

Mexico

1

Argentina

1

Brazil

1

China

1

South Africa

1

Hungary

1

Taiwan

1

European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic